
|Articles|January 15, 2003
Improved form of brimonidine has fewer contraindications
Brimonidine tartrate 0.15% (Alphagan P, Allergan) is a "new and improved" version of brimonidine 0.2% (Alphagan, Allergan). It continues to have an efficacy profile similar to the one ophthalmologists have grown used to with brimonidine 0.2%.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
What if? Ophthalmology without OCT – Part 5
2
LASIK and beyond: Navigating the changing landscape of refractive surgery
3
Q&A: James Chelnis discusses AAO 2025 presentation on aesthetic facial surgery
4
Transformative advances in vision research: It’s the science
5


















































.png)


